CUEDC1 and prostate adenocarcinoma: We first found that CUEDC1 was significantly downregulated in adrenocortical carcinoma, bladder urothelial carcinoma, colon adenocarcinoma, kidney renal clear cell carcinoma, prostate adenocarcinoma and thyroid carcinoma tissues (Supplementary Figure 1A).